Jeffries is seeing signs that Unity's AI-powered digital-advertising platform could power a comeback for the company. Unity ...

Fourth, CLF’s valuation is a house of cards. The firm’s 8.5x 2029E EV/EBITDA multiple, discounted to 2025E, yields a price target of $3.91 (-38.7% downside). Risks skew heavily downward unless tariffs ...

Navitas' valuation has surged well above sector peers, lowering the opportunity for near-term upside. Click here to find out ...

Free cash flow swung positive, hitting $7 million from a $15 million deficit a year ago a promising sign, but investors aren't sold yet. The stock dropped ... The AI-driven Vector platform is ...

ON24 continues to lose customers, ARR, and revenue, with little evidence of AI-driven innovation. Read why investors should ...

The NFU has set out some tips for minimising the spread of disease between livestock when attending agricultural shows and ...

VANCOUVER, BC / ACCESS Newswire / June 2, 2025 / Tectonic Metals Inc. ("Tectonic" or the "Company") (TSX-V:TECT) (OTCQB:TETOF ...

Some pseudonyms are used to protect the identities of interviewees. “I saw a lot of suffering.” The old man, Lokwi, gestures ...

The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, ...

Summer is normally the quietest period for vets and suckler farmers but there are a number of important issues that can catch ...

Rocket Pharmaceuticals acknowledged the death of a patient in a pivotal trial assessing its Danon disease gene therapy candidate RP-A501, a study that the FDA has placed on clinical hold.

Detailed price information for D-Wave Quantum Inc (QBTS-N) from The Globe and Mail including charting and trades.